ImmuCell Revenue 2006-2019 | ICCC

ImmuCell revenue from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
ImmuCell Annual Revenue
(Millions of US $)
2018 $11
2017 $10
2016 $10
2015 $10
2014 $8
2013 $6
2012 $5
2011 $5
2010 $4
2009 $5
2008 $5
2007 $6
2006 $5
2005 $5
ImmuCell Quarterly Revenue
(Millions of US $)
Q3 2019 $3
Q2 2019 $3
Q1 2019 $4
Q4 2018 $3
Q3 2018 $2
Q2 2018 $3
Q1 2018 $3
Q4 2017 $3
Q3 2017 $2
Q2 2017 $2
Q1 2017 $4
Q4 2016 $2
Q3 2016 $2
Q2 2016 $2
Q1 2016 $3
Q4 2015 $3
Q3 2015 $2
Q2 2015 $2
Q1 2015 $3
Q4 2014 $2
Q3 2014 $2
Q2 2014 $2
Q1 2014 $2
Q4 2013 $2
Q3 2013 $1
Q2 2013 $1
Q1 2013 $2
Q4 2012 $1
Q3 2012 $1
Q2 2012 $1
Q1 2012 $2
Q4 2011 $1
Q3 2011 $1
Q2 2011 $1
Q1 2011 $2
Q4 2010 $1
Q3 2010 $1
Q2 2010 $1
Q1 2010 $1
Q4 2009 $1
Q3 2009 $1
Q2 2009 $1
Q1 2009 $1
Q4 2008 $1
Q3 2008 $1
Q2 2008 $1
Q1 2008 $2
Q4 2007 $2
Q3 2007 $2
Q2 2007 $1
Q1 2007 $2
Q4 2006 $1
Q3 2006 $1
Q2 2006 $1
Q1 2006 $2
Q4 2005 $1
Q3 2005 $1
Q2 2005 $1
Q1 2005 $2
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.037B $0.011B
ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM, a human application of its milk-derived passive antibodytechnology for use as an alternative to antibiotics in the treatment and/or prevention of Clostridium difficile-associated diarrhea.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $150.160B 27.39
Medtronic (MDT) Ireland $149.747B 20.69
Stryker (SYK) United States $74.065B 24.90
Boston Scientific (BSX) United States $61.077B 28.83
Baxter (BAX) United States $42.381B 25.70
Essilor Luxottica (ESLOY) France $33.712B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.238B 18.97
Terumo (TRUMY) Japan $26.963B 33.65
Lonza Group Ag (LZAGY) Switzerland $25.222B 0.00
Coloplast (CLPBY) Denmark $24.840B 38.33
ResMed (RMD) United States $21.637B 39.92
Smith & Nephew SNATS (SNN) United Kingdom $19.607B 0.00
Sunny Optical Technology (SNPTF) China $19.217B 0.00
Insulet (PODD) United States $11.140B 529.97
Bio-Rad Laboratories (BIO) United States $10.533B 50.56
DiaSorin S.p.A (DSRLF) Italy $7.616B 0.00
William Demant Holdings (WILYY) Denmark $7.531B 0.00
Perrigo (PRGO) Ireland $7.324B 13.66
Hill-Rom Holdings (HRC) United States $7.238B 21.34
Canopy Growth (CGC) Canada $7.058B 0.00
Haemonetics (HAE) United States $5.958B 40.26
Shandong Weigao Medical Polymer (SHWGF) China $5.743B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
NuVasive (NUVA) United States $3.840B 30.24
ICU Medical (ICUI) United States $3.692B 24.07
Neogen (NEOG) United States $3.546B 59.33
GW Pharmaceuticals (GWPH) United Kingdom $3.178B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.061B 0.00
Quidel (QDEL) United States $2.984B 28.32
Aurora Cannabis (ACB) Canada $2.669B 0.00
Agios Pharmaceuticals (AGIO) United States $2.596B 0.00
National Vision Holdings (EYE) United States $2.423B 54.70
Cardiovascular Systems (CSII) United States $1.542B 0.00
InMode (INMD) Israel $1.364B 0.00
Aphria (APHA) $1.230B 0.00
AtriCure (ATRC) United States $1.218B 0.00
VAREX IMAGING (VREX) United States $1.182B 23.68
Phibro Animal Health (PAHC) United States $0.986B 18.46
NanoString Technologies (NSTG) United States $0.908B 0.00
TG Therapeutics (TGTX) United States $0.890B 0.00
Lantheus Holdings (LNTH) United States $0.803B 20.07
Eagle Pharmaceuticals (EGRX) United States $0.803B 30.76
Quanterix (QTRX) United States $0.704B 0.00
LeMaitre Vascular (LMAT) United States $0.697B 39.17
PetIQ (PETQ) United States $0.695B 16.97
Omeros (OMER) United States $0.662B 0.00
HEXO (HEXO) $0.563B 0.00
Cerus (CERS) United States $0.540B 0.00
Surmodics (SRDX) United States $0.532B 55.32
OraSure Technologies (OSUR) United States $0.485B 29.07
MacroGenics (MGNX) United States $0.474B 0.00
Owens & Minor (OMI) United States $0.445B 16.47
Organigram Holdings (OGI) Canada $0.400B 0.00
Meridian Bioscience (VIVO) United States $0.395B 13.57
Utah Medical Products (UTMD) United States $0.388B 28.08
BioLife Solutions (BLFS) United States $0.309B 125.75
Zynex (ZYXI) United States $0.293B 33.19
Bovie Medical (APYX) United States $0.273B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.265B 0.00
United Health Products (UEEC) United States $0.245B 0.00
Viemed Healthcare (VMD) United States $0.244B 25.76
Vapotherm (VAPO) United States $0.244B 0.00
Repro-Med Systems (KRMD) United States $0.239B 0.00
Liberty Health Sciences (LHSIF) Canada $0.179B 0.00
InfuSystems Holdings (INFU) United States $0.164B 824.00
Green Organic Dutchman Holdings (TGODF) Canada $0.160B 0.00
Female Health (VERU) United States $0.159B 0.00
Rockwell Medical (RMTI) United States $0.147B 0.00
MTech Acquisition (KERN) United States $0.132B 0.00
Cytosorbents (CTSO) United States $0.129B 0.00
Fonar (FONR) United States $0.127B 8.98
Chimerix (CMRX) United States $0.116B 0.00
United-Guardian (UG) United States $0.091B 22.91
Oramed Pharmaceuticals (ORMP) United States $0.090B 0.00
Chembio Diagnostics (CEMI) United States $0.076B 0.00
Nephros (NEPH) United States $0.066B 0.00
MRI Interventions (MRIC) United States $0.063B 0.00
Surface Oncology (SURF) United States $0.051B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Senestech (SNES) United States $0.016B 0.00
Valeritas Holdings (VLRX) United States $0.015B 0.00
GUARDION HEALTH (GHSI) United States $0.014B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
Myomo (MYO) United States $0.008B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00